# Methylglyoxal Evaluation in Humans

> **NCT05350553** · — · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 39 (actual)

## Conditions studied

- Type 2 Diabetes
- Neuropathy, Painful
- Chronic Low-back Pain
- Lumbar Disc Herniation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05350553
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-02
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05350553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05350553, "Methylglyoxal Evaluation in Humans". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05350553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*